Skip to main content
. Author manuscript; available in PMC: 2015 Aug 3.
Published in final edited form as: Cancer Res. 2014 Aug 1;74(15):4065–4077. doi: 10.1158/0008-5472.CAN-13-2679

Figure 2.

Figure 2

Adjusted cumulative probability of 5-year breast cancer–specific mortality for aspirin users and nonusers in the full cohort and by lymph node status at diagnosis (positive, negative), adjusted for age, tumor stage, tumor grade, ER, PR, HER2, and comorbidity.